Skip to main content
Premium Trial:

Request an Annual Quote

Not to Belabor the Point, But ...

It's been four whole days since our last post on Navigenics, so we're ready for another one. This blog post comes from Science Roll, where Bertalan Meskó takes on the challenge of reviewing three would-be personalized medicine companies which have, for the most part, not made any clear public statements about what exactly they will be doing. The post, which reviews 23andMe, Navigenics, and Helix Health, centers on information from their websites and looks at the services the companies plan to offer.

Meskó's upshot: The ideal company would merge Navigenics' team and business model with 23andMe's financial backing and "the personal aspect of Helix Health." Sounds like a tie to GTO.

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.